| More than just protein building blocks: how amino acids and related metabolic pathways fuel macrophage polarization M Kieler, M Hofmann, G Schabbauer The FEBS journal 288 (12), 3694-3714, 2021 | 104 | 2021 |
| 3D approaches to model the tumor microenvironment of pancreatic cancer E Tomás-Bort, M Kieler, S Sharma, JB Candido, D Loessner Theranostics 10 (11), 5074, 2020 | 95 | 2020 |
| Environmental arginine controls multinuclear giant cell metabolism and formation JS Brunner, L Vulliard, M Hofmann, M Kieler, A Lercher, A Vogel, ... Nature communications 11 (1), 431, 2020 | 43 | 2020 |
| A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid M Kieler, M Unseld, D Bianconi, W Scheithauer, GW Prager Therapeutic advances in medical oncology 11, 1758835919853196, 2019 | 41 | 2019 |
| Impact of new chemotherapy regimens on the treatment landscape and survival of locally advanced and metastatic pancreatic cancer patients M Kieler, M Unseld, D Bianconi, M Schindl, GV Kornek, W Scheithauer, ... Journal of Clinical Medicine 9 (3), 648, 2020 | 30 | 2020 |
| The PI3K pathway preserves metabolic health through MARCO-dependent lipid uptake by adipose tissue macrophages JS Brunner, A Vogel, A Lercher, M Caldera, A Korosec, M Puehringer, ... Nature Metabolism 2 (12), 1427-1442, 2020 | 27 | 2020 |
| Metachronous hepatic resection for liver only pancreatic metastases C Schwarz, F Fitschek, F Primavesi, S Stättner, GA Margonis, MA Weiss, ... Surgical oncology 35, 169-173, 2020 | 26 | 2020 |
| Task-dependent variability of essential tremor N Schuhmayer, C Weber, M Kieler, B Voller, W Pirker, E Auff, ... Parkinsonism & related disorders 41, 79-85, 2017 | 24 | 2017 |
| Optimizing treatment sequence for late-line metastatic colorectal cancer patients using trifluridine/tipiracil and regorafenib M Unseld, M Drimmel, A Siebenhüner, A Gleiss, D Bianconi, M Kieler, ... Clinical colorectal cancer 17 (4), 274-279, 2018 | 22 | 2018 |
| JAK1 signaling in dendritic cells promotes peripheral tolerance in autoimmunity through PD-L1-mediated regulatory T cell induction A Vogel, K Martin, K Soukup, A Halfmann, M Kerndl, JS Brunner, ... Cell Reports 38 (8), 2022 | 20 | 2022 |
| Challenges and perspectives for immunotherapy in adenocarcinoma of the pancreas: the cancer immunity cycle M Kieler, M Unseld, D Bianconi, G Prager Pancreas 47 (2), 142-157, 2018 | 19 | 2018 |
| Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational … D Bianconi, M Herac, F Posch, M Schmeidl, M Unseld, M Kieler, ... Therapeutic Advances in Medical Oncology 12, 1758835920928635, 2020 | 16 | 2020 |
| Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology GW Prager, M Unseld, F Waneck, R Mader, F Wrba, M Raderer, ... Oncotarget 10 (9), 942, 2019 | 14 | 2019 |
| Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky disease M Kieler, W Scheithauer, CC Zielinski, A Chott, A Al-Mukhtar, G Prager ESMO open 1 (6), e000084, 2016 | 13 | 2016 |
| Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy M Kieler, M Unseld, J Wojta, A Kaider, D Bianconi, S Demyanets, ... Medical Oncology 36 (1), 1, 2019 | 12 | 2019 |
| SERPINB7 expression predicts poor pancreatic cancer survival upon gemcitabine treatment D Bianconi, M Herac, D Spies, M Kieler, R Brettner, M Unseld, ... Translational oncology 12 (1), 15-23, 2019 | 12 | 2019 |
| Regorafenib therapy in metastatic colorectal cancer patients: markers and outcome in an actual clinical setting. M Unseld, M Filip, S Seirl, A Gleiss, D Bianconi, M Kieler, S Demyanets, ... Neoplasma 65 (4), 599-603, 2018 | 10 | 2018 |
| Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI M Kieler, M Unseld, D Bianconi, F Waneck, R Mader, F Wrba, T Fuereder, ... ESMO open 4 (4), e000538, 2019 | 9 | 2019 |
| Analysis of 10 adrenocortical carcinoma patients in the cohort of the precision medicine platform MONDTI M Kieler, L Müllauer, O Koperek, D Bianconi, M Unseld, M Raderer, ... Oncology 94 (5), 306-310, 2018 | 8 | 2018 |
| Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel D Bianconi, G Heller, D Spies, M Herac, A Gleiss, S Liebmann-Reindl, ... Scientific reports 7 (1), 4851, 2017 | 7 | 2017 |
Christoph ZielinskiProfessor of Medical Oncology, Medical University ViennaVerified email at meduniwien.ac.at
